The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts - PubMed (original) (raw)
The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts
G Q Daley et al. Science. 1987.
Abstract
The v-abl oncogene of the Abelson murine leukemia virus (A-MuLV) is known to efficiently transform NIH/3T3 fibroblasts in vitro and to cause an acute lymphosarcoma in susceptible murine hosts. The role of its relative, the bcr/abl gene product, in the etiology of human chronic myelogenous leukemia (CML) remains speculative. To assess the transforming properties of the bcr/abl gene product, complementary DNA clones encoding the CML-specific P210 bcr/abl protein were expressed in NIH/3T3 fibroblasts. In contrast to the v-abl oncogene product P160, the P210 bcr/abl gene product did not transform NIH/3T3 cells. Cell lines were isolated that expressed high levels of the P210 bcr/abl protein but were morphologically normal. During the course of these experiments, a transforming recombinant of bcr/abl was isolated which fuses gag determinants derived from helper virus to the NH2-terminus of the bcr/abl protein. This suggests that a property of viral gag sequences, probably myristylation-dependent membrane localization, must be provided to bcr/abl for it to transform fibroblasts.
Similar articles
- The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.
Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D. Ben-Neriah Y, et al. Science. 1986 Jul 11;233(4760):212-4. doi: 10.1126/science.3460176. Science. 1986. PMID: 3460176 - Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW, Ren R. Gross AW, et al. Oncogene. 2000 Dec 14;19(54):6286-96. doi: 10.1038/sj.onc.1204023. Oncogene. 2000. PMID: 11175343 - Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
Rees-Jones RW, Goff SP. Rees-Jones RW, et al. J Virol. 1988 Mar;62(3):978-86. doi: 10.1128/JVI.62.3.978-986.1988. J Virol. 1988. PMID: 2828693 Free PMC article. - Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.
Daley GQ, Baltimore D. Daley GQ, et al. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9312-6. doi: 10.1073/pnas.85.23.9312. Proc Natl Acad Sci U S A. 1988. PMID: 3143116 Free PMC article. - The molecular biology of chronic myeloid leukaemia.
Melo JV. Melo JV. Leukemia. 1996 May;10(5):751-6. Leukemia. 1996. PMID: 8656667 Review.
Cited by
- Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.
Kelliher M, Knott A, McLaughlin J, Witte ON, Rosenberg N. Kelliher M, et al. Mol Cell Biol. 1991 Sep;11(9):4710-6. doi: 10.1128/mcb.11.9.4710-4716.1991. Mol Cell Biol. 1991. PMID: 1875948 Free PMC article. - A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells.
Kabarowski JH, Allen PB, Wiedemann LM. Kabarowski JH, et al. EMBO J. 1994 Dec 15;13(24):5887-95. doi: 10.1002/j.1460-2075.1994.tb06934.x. EMBO J. 1994. PMID: 7813429 Free PMC article. - Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.
McLaughlin J, Chianese E, Witte ON. McLaughlin J, et al. Mol Cell Biol. 1989 May;9(5):1866-74. doi: 10.1128/mcb.9.5.1866-1874.1989. Mol Cell Biol. 1989. PMID: 2747638 Free PMC article. - Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.
Young JC, Witte ON. Young JC, et al. Mol Cell Biol. 1988 Oct;8(10):4079-87. doi: 10.1128/mcb.8.10.4079-4087.1988. Mol Cell Biol. 1988. PMID: 3263566 Free PMC article. - Human bcr-abl gene has a lethal effect on embryogenesis.
Heisterkamp N, Jenster G, Kioussis D, Pattengale PK, Groffen J. Heisterkamp N, et al. Transgenic Res. 1991 Dec;1(1):45-53. doi: 10.1007/BF02512996. Transgenic Res. 1991. PMID: 1726940
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous